"The Report HistoGeneX NV
- Product Pipeline Analysis, 2016 Update provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
HistoGeneX
NV (HistoGeneX) is a biotechnology company that offers clinical
research services. The company offers research, clinical research and
patient testing services. It handles human biological specimens and
deploys technologies to interrogate the DNA, RNA and proteins to
categorize, enumerate and understand cancer for research and
diagnostic applications. HistoGeneX provides biomarker assay
development and validation services, TMA services, skin nerve fiber
assay, pathology and biomarker assessment services. It offers
morphology based tests that include IHC, IF, real-time PCR,
epigenetics, multi-analyte IHC/IF and spectral imaging. The company
offers tissue morphology-based lab research services to
pharmaceutical, medical device, and academic clients. HistoGeneX is
headquartered in Antwerpen, Belgium.
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The
report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage.
View
Report @ http://www.marketresearchreports.biz/analysis/954999
Scope:
- The report reviews detailed
company profile with information on business description, key company
facts, major products and services, key competitors, key employees,
locations and subsidiaries and recent developments
- The report analyzes all pipeline
products in development for the company HistoGeneX NV
- The report provides pipeline
analysis on all pipeline products of the company (by equipment type,
by indication, by development stage, and by trial status)
- The report covers detailed
information on each pipeline product with information on pipeline
territory, stage of development, device class, regulatory path,
indication(s), application(s) and estimated launch date
- The report provides detailed
description of products in development, technical specification and
functions
- The report also covers ongoing
clinical trials (wherever applicable) with information on trial name,
trial objective, sponsor, trial design , trial status and phase,
estimated start and end date.
Get
Sample Copy Of This Report @
Reasons to Buy:
- Develop business strategies by
understanding the trends and developments driving the medical devices
pipeline and technology landscape
- Design and develop your product
development, marketing and sales strategies by understanding the
competitor portfolio
- To formulate effective Research
& Development strategies
- Develop market-entry and market
expansion strategies
- Exploit in-licensing and
out-licensing opportunities by identifying products, most likely to
ensure a robust return
- Plan mergers and acquisitions
effectively by identifying key players of the most promising pipeline
- Identify emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop competition strategies
by identifying the status and likely launch of the competitors
pipeline products through review of the clinical trials, stage and of
development, etc
- Identify, understand and
capitalize the next high-value products that your competitor would
add in its portfolio
Table of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 4
HistoGeneX
NV Company Overview 5
HistoGeneX
NV Company Snapshot 5
HistoGeneX
NV Pipeline Products and Clinical Trials Overview 5
HistoGeneX
NV Pipeline Analysis Overview 8
Key
Facts 8
HistoGeneX
NV - Major Products and Services 9
HistoGeneX
NV Pipeline Products by Development Stage 10
HistoGeneX
NV Pipeline Products Overview 12
IHC
Based Diagnostic Assay - Bcl-2:IGH 12
IHC
Based Diagnostic Assay - Bcl-2:IGH Product Overview 12
IHC
Based Diagnostic Assay - BRCA 13
IHC
Based Diagnostic Assay - BRCA Product Overview 13
IHC
Based Diagnostic Assay - EBER 14
IHC
Based Diagnostic Assay - EBER Product Overview 14
IHC
Based Diagnostic Assay - GATA-3 15
IHC
Based Diagnostic Assay - GATA-3 Product Overview 15
IHC
Based Diagnostic Assay - HLA - DR 16
IHC
Based Diagnostic Assay - HLA - DR Product Overview 16
IHC
Based Diagnostic Assay - HPV 17
IHC
Based Diagnostic Assay - HPV Product Overview 17
IHC
Based Diagnostic Assay - ICOS 18
IHC
Based Diagnostic Assay - ICOS Product Overview 18
IHC
Based Diagnostic Assay - IDO 19
IHC
Based Diagnostic Assay - IDO Product Overview 19
IHC
Based Diagnostic Assay - Phospho-PRAS40 20
IHC
Based Diagnostic Assay - Phospho-PRAS40 Product Overview 20
IHC
Based Diagnostic Assay - Phospho-STAT3 21
IHC
Based Diagnostic Assay - Phospho-STAT3 Product Overview 21
IHC
Based Diagnostic Assay - Vimentin 22
IHC
Based Diagnostic Assay - Vimentin Product Overview 22
IHC
Based Diagnostic Assay - VISTA 23
IHC
Based Diagnostic Assay - VISTA Product Overview 23
IHC
Based Diagnostic Assay -E-cadherin 24
IHC
Based Diagnostic Assay -E-cadherin Product Overview 24
HistoGeneX
NV - Key Competitors 25
HistoGeneX
NV - Key Employees 26
HistoGeneX
NV - Locations And Subsidiaries 27
Head
Office 27
Recent
Developments 28
HistoGeneX
NV, Recent Developments 28
Jun
02, 2014: MDxHealth and HistoGeneX Awarded $1.8 Million IWT Grant to
Develop Companion Diagnostics for Cancer Immunotherapy 28
Appendix
29
Methodology
29
About
GlobalData 29
Contact
Us 29
Disclaimer
29
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment